BRUSSELS (Reuters) — The European Union’s nominee for health chief has pledged to oppose the import of some U.S. food, which Washington hopes to be able to sell to Europe under a planned trade deal.
In comments at his confirmation hearing in the European Parliament that will delight EU heavyweights France and Germany, Vytenis Andriukaitis singled out chemically treated meat and genetically modified crops, which he said posed a “philosophical problem” that threatened Europe’s biodiversity.
The United States, now in negotiations with the EU on a free trade pact that would create a joint market of 800 million people, wants the 28-nation bloc to take a more science-based approach to GM crops and hormone-treated meat.
Read Also
Rented farmland jumps 3.4 million acres in Saskatchewan and Alberta
Farmland rented or leased in the two provinces went from 25.7 million acres in 2011 to 29.1 million in 2021, says Census of Agriculture data.
“I cannot make any compromises on this issue, whether it is hormones in meat or chlorine baths for poultry,” Andriukaitis told EU lawmakers in the hearing on his nomination to be head of health and food safety policy in the next European Commission.
The Lithuanian nominee urged caution when EU lawmakers from across the political spectrum repeatedly asked where he stood on GM crops, which are widely grown in the Americas and Asia.
“Cultivation of GMOs is a huge problem from a philosophical point of view,” said Andriukaitis, a doctor by training. “If we want to interfere with biodiversity, we have to be very vigilant and cautious.”
There is strong opposition in a number of EU member states, including France and Germany, to GM food, growth hormones in cattle and chicken that is disinfected with chemicals.
Andriukaitis’s stance signals further tension in the talks to clinch the trade deal, which proponents say must also break down farm trade barriers to deliver the greatest benefits.
An accord would allow the EU to sell more of its luxury cars, trains and chemicals in the United States, an attractive prospect for an economy whose slow recovery from the euro zone debt crisis is faltering.
Selling the benefits of a deal, which could generate $100 billion a year in economic growth for both the EU and the U.S., has also been complicated by concerns about U.S. companies becoming too powerful.
The EU’s designated trade commissioner, Cecilia Malmstrom of Sweden, told EU lawmakers that provisions for investor arbitration — the investor-state dispute settlement — could be dropped from the free trade deal.
Andriukaitis also promised to review the EU’s GM approval process in the first six months of his mandate.
The EU decided in May to make approval of GM crops easier but to allow some countries to ban them.
In the case of GM crops, the EU has cleared 50 of 450 commercial strains for import. The EU imports 30 million tonnes a year of GM grain for its cattle, pigs and poultry, but EU retailers hardly stock any GM food because of stiff consumer resistance.
